Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Glutaminase ELISA Kit (AC3775)
Cat.#: ASET-2364
Specifications
Description Human Glutaminase ELISA Kit allows for the in vitro quantitative determination of human Glutaminase concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1961 Mouse Antidiuretic Hormone ELISA Kit (AC3372) Quantitative inquiry ASET-1097 Mouse Wnt3a ELISA Kit (AC2508) Quantitative inquiry ASET-1835 Human Hemojuvelin ELISA Kit (AC3246) Quantitative inquiry ASET-2182 Human Midkine ELISA Kit (AC3593) Quantitative inquiry ASET-1865 Rat Mu Opioid Receptor ELISA Kit (AC3276) Quantitative inquiry ASET-2362 Mouse GJB2 ELISA Kit (AC3773) Quantitative inquiry ASET-1622 Human ASRGL1 ELISA Kit (AC3033) Quantitative inquiry ASET-1887 Mouse Mtnr1a ELISA Kit (AC3298) Quantitative inquiry ASET-1434 Rat Rabphilin 3A ELISA Kit (AC2845) Quantitative inquiry ASET-1326 Human MEF2A ELISA Kit (AC2737) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket